It is a pharma private limited company based in Lucknow, Uttar Pradesh, India, established in 2014.
2014 | Lucknow, Uttar Pradesh, India | ActiveSampra Pharma Private Limited, a active private limited company, was established on 17 January 2014 in Lucknow, Uttar Pradesh, India. Engaging in drug formulation & development within the pharma sector, it holds CIN: U24100UP2014PTC062039. Registered under ROC Roc Kanpur. it is unlisted. It has an authorized capital of ₹0.20 M and a paid-up capital of ₹1.00 M.
It upholds a compliant status. Its leadership includes Shailesh Prabhunath Gupta (Director), Sunil Singh (Director). Past directors included Barun Kumar Singh, Indrajeet Singh, Indraneel Madhukar. It holds ₹0.80 M open charges and no settled loans. Its latest AGM occurred on 21 September 2022, with the balance sheet filed on 31 March 2022. It is based at Es-1/216,217,Sector-A,Sry Paltan Chhavni,Aliganj, Lucknow, Uttar Pradesh, 226021.
U24100UP2014PTC062039
062039
17 January 2014
₹0.20 M
₹1.00 M
Roc Kanpur
Unlisted
Active
Explore comprehensive insights into Sampra Pharma Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Shailesh Prabhunath Gupta | Director | 16 Jul 2022 | Current |
| Sunil Singh | Director | 18 Jan 2024 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 18 Jan 2024 | Past |
| Pramod Abcsdd | Director | 16 Jul 2022 | Past |
| Pramod Abcsdd | Director | 16 Jul 2022 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Sampra Pharma Private Limited, for the financial year ended 2019, experienced significant reduction in revenue, with a 57.47% decrease. The company also saw a substantial fall in profitability, with a 647.12% decrease in profit. The company's net worth dipped by a decrease of 3.28%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2019, Sampra Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹800,000.00
₹0
| Date | Lender | Amount | Status |
|---|---|---|---|
| 17 Aug 2018 | United Bank Of India | ₹0.80 M | Open |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Sampra Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Sampra Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sampra Pharma's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Sunil Singh was appointed as a Director was appointed as a Director on 18 Jan 2024 & has been associated with this company since 1 year 10 months . was recorded as a recent event.
The activity Sampra Pharma Private Limited last Annual general meeting of members was held on 21 Sep 2022 as per latest MCA records. was completed.
Shailesh Prabhunath Gupta was appointed as a Director was appointed as a Director on 16 Jul 2022 & has been associated with this company since 3 years 4 months . was recorded as a recent event.
The activity Sampra Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2022 with Roc Kanpur. was completed.
Progress on A charge with United Bank Of India amounted to Rs. 0.80 M with Charge ID 100201212 was registered on 17 Aug 2018. was documented.
Progress on Sampra Pharma Private Limited was registered on 17 Jan 2014 with Roc Kanpur & aged 11 years 10 months as per MCA records. was documented.
The CIN of Sampra Pharma Private Limited is U24100UP2014PTC062039.
Sampra Pharma Private Limited is headquartered at Es-1/216,217,Sector-A,Sry Paltan Chhavni,Aliganj, Lucknow, Uttar Pradesh, 226021.
Sampra Pharma Private Limited was incorporated on 17 January 2014.
The current directors of Sampra Pharma Private Limited are
The primary industry of Sampra Pharma Private Limited is Pharma.
Sampra Pharma Private Limited is unlisted.
The authorized capital of Sampra Pharma Private Limited is ₹0.20 M, and the paid-up capital is ₹1.00 M.
The compliance status of Sampra Pharma Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX